ATE289806T1 - Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein - Google Patents
Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein proteinInfo
- Publication number
- ATE289806T1 ATE289806T1 AT98934120T AT98934120T ATE289806T1 AT E289806 T1 ATE289806 T1 AT E289806T1 AT 98934120 T AT98934120 T AT 98934120T AT 98934120 T AT98934120 T AT 98934120T AT E289806 T1 ATE289806 T1 AT E289806T1
- Authority
- AT
- Austria
- Prior art keywords
- lipid
- protein
- active ingredient
- pharmaceutical compositions
- particles containing
- Prior art date
Links
- 150000002632 lipids Chemical group 0.000 title abstract 6
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000265 homogenisation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 125000003473 lipid group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702776A SE9702776D0 (sv) | 1997-07-22 | 1997-07-22 | Method of preparing pharmaceutical compositions |
| PCT/SE1998/001407 WO1999004761A1 (en) | 1997-07-22 | 1998-07-22 | Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE289806T1 true ATE289806T1 (de) | 2005-03-15 |
Family
ID=20407807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98934120T ATE289806T1 (de) | 1997-07-22 | 1998-07-22 | Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1014947B1 (de) |
| JP (1) | JP3813439B2 (de) |
| AT (1) | ATE289806T1 (de) |
| AU (1) | AU744738B2 (de) |
| CA (1) | CA2297924C (de) |
| DE (1) | DE69829191T2 (de) |
| ES (1) | ES2236919T3 (de) |
| NO (1) | NO20000330L (de) |
| NZ (1) | NZ502840A (de) |
| PT (1) | PT1014947E (de) |
| SE (1) | SE9702776D0 (de) |
| WO (1) | WO1999004761A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8206749B1 (en) * | 1999-02-26 | 2012-06-26 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions with adsorbed macromolecules and microparticles |
| AU2596401A (en) * | 1999-12-22 | 2001-07-03 | Surgical Sealants, Inc. | Methods and compositions for sealing tissue leaks |
| CZ20013523A3 (cs) * | 2000-02-02 | 2002-03-13 | Florida State University Research Foundation, Inc. | Taxany s C10 heterosubstituovaným acetátem jako protinádorové látky |
| US6514523B1 (en) * | 2000-02-14 | 2003-02-04 | Ottawa Heart Institute Research Corporation | Carrier particles for drug delivery and process for preparation |
| CA2407027C (en) * | 2000-04-20 | 2011-02-15 | Rtp Pharma Inc. | Improved water-insoluble drug particle process |
| US6599441B1 (en) * | 2000-07-18 | 2003-07-29 | Emerald Biostructures, Inc. | Crystallization solutions |
| CN101284136A (zh) | 2002-12-03 | 2008-10-15 | 布朗歇特洛克菲勒神经科学研究所 | 传输物质穿过血脑屏障的人工低密度脂蛋白载体 |
| US7803400B2 (en) | 2002-12-03 | 2010-09-28 | Blanchette Rockefeller Neurosciences Institute | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| KR100720213B1 (ko) * | 2003-04-04 | 2007-05-21 | 화이자 프로덕츠 인코포레이티드 | 미세 유동화된 수중 유적형 유화액 및 백신 조성물 |
| JP4050784B2 (ja) * | 2005-02-03 | 2008-02-20 | 株式会社Nrlファーマ | マトリックス型腸溶性・徐放性組成物 |
| US7951396B2 (en) * | 2005-03-28 | 2011-05-31 | Regeron, Inc. | Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome |
| US20070151853A1 (en) * | 2005-12-29 | 2007-07-05 | Invitrogen Corporation | Compositions and Methods for Improving Resolution of Biomolecules Separated on Polyacrylamide Gels |
| EP1915986A1 (de) | 2006-10-23 | 2008-04-30 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Wachstumsfaktorhaltige Lipidformulierungen |
| CH715456B1 (de) | 2007-04-27 | 2020-04-30 | Mibelle Ag | Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet. |
| US8071759B2 (en) | 2008-07-18 | 2011-12-06 | Affymetrix, Inc. | Water soluble cholesterol derivatives |
| US8734853B2 (en) | 2008-11-17 | 2014-05-27 | University Of North Texas Health Science Center At Fort Worth | HDL particles for delivery of nucleic acids |
| JP4912510B2 (ja) * | 2009-08-31 | 2012-04-11 | ナノキャリア株式会社 | 粒子組成物及びこれを有する医薬組成物 |
| US20160346221A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
| WO2025215934A1 (ja) * | 2024-04-09 | 2025-10-16 | コニカミノルタ株式会社 | 予測装置、予測装置の粒径分布予測方法、および粒径分布予測プログラム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128318A (en) * | 1987-05-20 | 1992-07-07 | The Rogosin Institute | Reconstituted HDL particles and uses thereof |
| IL86799A (en) * | 1987-07-02 | 1993-03-15 | Kabi Pharmacia Ab | Method and device for injection |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5652339A (en) * | 1993-12-31 | 1997-07-29 | Rotkreuzstiftung Zentrallaboratorium | Method of producing reconstituted lipoproteins |
-
1997
- 1997-07-22 SE SE9702776A patent/SE9702776D0/xx unknown
-
1998
- 1998-07-22 AU AU83718/98A patent/AU744738B2/en not_active Ceased
- 1998-07-22 EP EP98934120A patent/EP1014947B1/de not_active Expired - Lifetime
- 1998-07-22 WO PCT/SE1998/001407 patent/WO1999004761A1/en not_active Ceased
- 1998-07-22 NZ NZ502840A patent/NZ502840A/xx unknown
- 1998-07-22 PT PT98934120T patent/PT1014947E/pt unknown
- 1998-07-22 ES ES98934120T patent/ES2236919T3/es not_active Expired - Lifetime
- 1998-07-22 CA CA002297924A patent/CA2297924C/en not_active Expired - Fee Related
- 1998-07-22 DE DE69829191T patent/DE69829191T2/de not_active Expired - Fee Related
- 1998-07-22 JP JP2000503821A patent/JP3813439B2/ja not_active Expired - Fee Related
- 1998-07-22 AT AT98934120T patent/ATE289806T1/de not_active IP Right Cessation
-
2000
- 2000-01-21 NO NO20000330A patent/NO20000330L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69829191T2 (de) | 2005-07-21 |
| EP1014947B1 (de) | 2005-03-02 |
| SE9702776D0 (sv) | 1997-07-22 |
| NO20000330D0 (no) | 2000-01-21 |
| DE69829191D1 (de) | 2005-04-07 |
| WO1999004761A1 (en) | 1999-02-04 |
| CA2297924C (en) | 2007-04-10 |
| JP2001510786A (ja) | 2001-08-07 |
| ES2236919T3 (es) | 2005-07-16 |
| AU8371898A (en) | 1999-02-16 |
| CA2297924A1 (en) | 1999-02-04 |
| PT1014947E (pt) | 2005-05-31 |
| AU744738B2 (en) | 2002-02-28 |
| NO20000330L (no) | 2000-03-21 |
| NZ502840A (en) | 2002-08-28 |
| EP1014947A1 (de) | 2000-07-05 |
| JP3813439B2 (ja) | 2006-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE289806T1 (de) | Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein | |
| DE69802005D1 (de) | Kombination aus prolaminen und polaren pflanzlichen lipiden, verfahren zu deren herstellung sowie deren verwendungen | |
| FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
| ATE34078T1 (de) | Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion. | |
| ATE421318T1 (de) | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben | |
| ATE232543T1 (de) | 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln | |
| DE69704426D1 (de) | Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung | |
| ES512977A0 (es) | "un metodo para preparar una composicion base de goma de mascar no adhesiva". | |
| DE3783039D1 (de) | Membran lipid zusammensetzung und verfahren zur herstellung. | |
| AU2309195A (en) | Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels | |
| EP1089968A4 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| BR9508034A (pt) | Processo e aparelhagem para a preparação de uma unidade comestível que se dissolve rapidamente a referida unidade composição para liberar um ingrediente ativo processo para administração de um ingrediente ativo a um hospedeiro humano e produto provisório para fabricação da unidade comestível | |
| EP0173664A3 (de) | Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung | |
| ATE204744T1 (de) | Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung | |
| ATE245445T1 (de) | Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen | |
| AU586410B2 (en) | New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions | |
| ATE176865T1 (de) | Liposomen enthaltend darin verkapselte proteine, verfahren zu ihrer herstellung sowie diese liposomen enthaltende pharmazeutische und kosmetische zubereitungen | |
| DE60323356D1 (de) | Zusammensetzungen enthaltend protein und fettsäure und verfahren zur herstellung | |
| DE59906705D1 (de) | Verfahren zur herstellung von arzneimitteln in fester darreichungsform aus pflanzlichen extrakten | |
| DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
| US4761278A (en) | Ladies aftershave preparation and method for its manufacture | |
| CN118717570A (zh) | 卡拉胶的用途、化妆品组合物及其制造方法、促进蜂王浆向皮肤的渗透的方法 | |
| JPH0564607B2 (de) | ||
| JP2946197B2 (ja) | 皮膚外用剤 | |
| IT8622105A0 (it) | Formulazioni idrosolubili di ubidecarenoni, procedimento per laloro preparazione e composizioni farmaceutiche che li compongono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1014947 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |